A detailed history of Munro Partners transactions in Insulet Corp stock. As of the latest transaction made, Munro Partners holds 227,240 shares of PODD stock, worth $74.8 Million. This represents 1.9% of its overall portfolio holdings.

Number of Shares
227,240
Previous 14,355 1483.0%
Holding current value
$74.8 Million
Previous $4.51 Billion 1455.54%
% of portfolio
1.9%
Previous 0.14%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 14, 2025

BUY
$277.3 - $352.82 $59 Million - $75.1 Million
212,885 Added 1483.0%
227,240 $70.2 Billion
Q2 2025

Aug 26, 2025

BUY
$238.57 - $327.47 $3.42 Million - $4.7 Million
14,355 New
14,355 $4.51 Billion
Q1 2025

Oct 10, 2025

BUY
$237.06 - $288.29 $1.54 Million - $1.87 Million
6,500 Added 45.28%
20,855 $5.48 Billion

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $22.8B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track Munro Partners Portfolio

Follow Munro Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Munro Partners, based on Form 13F filings with the SEC.

News

Stay updated on Munro Partners with notifications on news.